NCT05362630View on ClinicalTrials.gov

Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study

CompletedOBSERVATIONAL

Enrollment

28

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

May 31, 2025

Conditions

Graft Versus Host Disease, AcuteHematopoietic Stem Cell Transplantation

Trial Locations (1)

37137

IRCCS Burlo Garofolo, Trieste

All Listed Sponsors

lead

University of Pisa

OTHER